Results 91 to 100 of about 44,586 (279)

Predictive Value of Perioperative Blood Lactic Acid Levels for Postoperative Crisis in Myasthenia Gravis Patients Undergoing Thymectomy

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Postoperative myasthenic crisis (POMC), which occurs specifically after thymectomy in myasthenia gravis (MG) patients, is a serious complication with known risk factors such as prior myasthenic crisis. However, the predictive value of perioperative blood lactic acid levels (BLAL) for POMC remains unclear.
Jianyong Zou   +7 more
wiley   +1 more source

Diagnosis of thymoma [PDF]

open access: yesJournal of Clinical Pathology, 2006
The diagnosis of thymic epithelial neoplasm has been a topic of controversy for many years. Reasons for this include the lack of predictive value associated with the morphology of these tumours and the multiplicity of classification schemes and terminologies proposed over the years.
openaire   +2 more sources

Thymoma-associated multiorgan autoimmunity

open access: yesBMJ Case Reports, 2019
Thymoma-associated multiorgan autoimmunity is a relatively new term to describe the rare paraneoplastic syndrome that complicates thymoma, which can involve the thyroid, liver and intestine in addition to the skin.
C. Hung   +3 more
semanticscholar   +1 more source

Light Sensitivity in Myasthenia Gravis: Clinical Characteristics and Impact on Quality of Life

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Light sensitivity is occasionally reported in myasthenia gravis patients, yet its prevalence, clinical characteristics, and impact on disease severity and quality of life remain insufficiently explored. This study aimed to evaluate the frequency, clinical characteristics, and the correlation of light sensitivity with ...
Eleonora Sabatelli   +7 more
wiley   +1 more source

Myelodysplasia followed by Good's Syndrome: A unique manifestation associated with thymoma

open access: yesKaohsiung Journal of Medical Sciences, 2012
Good’s syndrome, also known as thymoma with combined immunodeficiency, is rare. The immunodeficiency may precede, arise concurrently with or follow the diagnosis of thymoma.
Ling-Ping Chen   +5 more
doaj   +1 more source

Acquired neuromyotonia in thymoma‐associated myasthenia gravis: a clinical and serological study

open access: yesEuropean Journal of Neurology, 2019
Acquired neuromyotonia can occur in patients with thymoma, alone or in association with myasthenia gravis (MG), but the clinical prognostic significance of such comorbidity is largely unknown.
M. Gastaldi   +16 more
semanticscholar   +1 more source

Frequency and Severity of Myasthenia Gravis Exacerbations Associated With the Use of Ciprofloxacin, Levofloxacin, and Azithromycin

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims The true frequency and severity of myasthenia gravis (MG) exacerbation associated with the usage of fluoroquinolone and macrolide antibiotics remain unknown. We aimed to investigate the association between ciprofloxacin, levofloxacin, azithromycin, and MG exacerbation.
Sanem Pinar Uysal   +3 more
wiley   +1 more source

Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization

open access: yesBMC Genomics, 2007
Background Thymoma is a heterogeneous group of tumors in biology and clinical behavior. Even though thymoma is divided into five subgroups following the World Health Organization classification, the nature of the disease is mixed within the subgroups ...
Park Chan   +7 more
doaj   +1 more source

Identification of PPFIA3 as a Potential Prognostic and Immune Biomarker Through Pan‐Cancer Analysis

open access: yesOrgan Medicine, EarlyView.
This study reveals a significant increase in the expression of PPFIA3 across various cancers, which is associated with poor prognosis. Notably, in patients receiving anti‐PD‐L1 treatment, high PPFIA3 expression is closely linked to improved survival rates and favorable prognosis, suggesting its potential as a predictive factor for immune checkpoint ...
Xianghong Wang   +4 more
wiley   +1 more source

Efficacy of rituximab in thymoma associated minimal change disease: case report

open access: yesBMC Nephrology, 2021
Background Thymomas have been associated with a broad spectrum of autoimmune diseases. Minimal change disease (MCD) is the most frequent pathological lesion reported. Pathophysiological mechanisms involved in secondary MCD, and linking MCD to thymoma are
Zhour El Ouafi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy